Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

Prostate cancer, a common malignancy in men, can rarely spread to the skin, a condition known as cutaneous metastasis. These skin lesions, often appearing in later stages, may manifest as nodules, ...

The 2025 ASTRO annual meeting featured a clinical trials session and a presentation by Dr. Amar Kishan discussing the primary ...

Prostate involvement was first reported in IgG4-RD approximately 2 decades ago and comprises only 9.6% of cases.

September is Prostate Cancer Awareness Month, and when many men choose to get check-ups.Though the month is nearly over, UAMS ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

Despite SBRT (radiation) to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

Following elevated PSA levels and subsequent tests, the author was diagnosed with prostate cancer. Post-treatment, the author's PSA levels returned to the normal range. The author encourages regular ...